Barclays

Barclays’s Vir Biotechnology VIR Stock Holding History

Barclays’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.21M	Sell	134,796 -231,030	-63%	-$1.84M	﹤0.01%	2637
2025 Q4	$2.21M	Sell	365,826 -44,580	-11%	-$265K	﹤0.01%	2864
2025 Q3	$2.34M	Sell	410,406 -63,252	-13%	-$323K	﹤0.01%	2771
2025 Q2	$2.39M	Buy	473,658 +262,035	+124%	+$1.4M	﹤0.01%	2712
2025 Q1	$1.37M	Sell	211,623 -9,555	-4%	-$85K	﹤0.01%	2920
2024 Q4	$1.62M	Sell	221,178 -329,008	-60%	-$2.6M	﹤0.01%	3055
2024 Q3	$4.12M	Buy	550,186 +7,287	+1%	+$63.3K	﹤0.01%	2256
2024 Q2	$4.83M	Sell	542,899 -471,780	-46%	-$4.52M	﹤0.01%	1561
2024 Q1	$10.3M	Buy	1,014,679 +569,985	+128%	+$5.8M	﹤0.01%	1370
2023 Q4	$4.47M	Buy	444,694 +32,533	+8%	+$297K	﹤0.01%	2192
2023 Q3	$3.86M	Buy	412,161 +228,634	+125%	+$3.26M	﹤0.01%	1492
2023 Q2	$4.5M	Sell	183,527 -48,975	-21%	-$1.23M	﹤0.01%	1413
2023 Q1	$5.41M	Buy	232,502 +36,277	+18%	+$928K	0.01%	1483
2022 Q4	$4.97M	Sell	196,225 -43,263	-18%	-$1.06M	﹤0.01%	1639
2022 Q3	$4.62M	Buy	239,488 +210,711	+732%	+$5.36M	0.01%	1217
2022 Q2	$734K	Sell	28,777 -72,114	-71%	-$1.68M	﹤0.01%	2577
2022 Q1	$2.6M	Buy	+100,891	New	+$2.99M	﹤0.01%	1668

Other funds holding VIR

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

GSK plc London $599M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return